pandemic influenza vaccine (H5N1 strain NIBRG-14)
PRO-PanFlu-1002
Phase 1 mab completed
Quick answer
pandemic influenza vaccine (H5N1 strain NIBRG-14) for Pandemic Influenza Vaccine is a Phase 1 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Pandemic Influenza Vaccine
- Phase
- Phase 1
- Modality
- mab
- Status
- completed